No­var­tis to cut up to 400 jobs at Dublin cam­pus

Weeks af­ter CEO Vas Narasimhan un­veiled a “US-first” strat­e­gy in re­shap­ing No­var­tis, the Swiss phar­ma gi­ant has re­vealed plans to cut around 400 jobs at its Dublin cam­pus by the end of 2024.

The cuts are part of a ma­jor re­struc­tur­ing that Narasimhan ini­ti­at­ed back in April, cut­ting out $1 bil­lion in costs and let­ting go of some key ex­ecs while com­bin­ing the phar­ma­ceu­ti­cals and on­col­o­gy units un­der one roof. In an at­tempt to achieve a “lean­er and sim­pler” busi­ness, No­var­tis is chop­ping 8,000 of 108,000 cur­rent roles world­wide, a spokesper­son told End­points News on Thurs­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER